Is Kratom Legal in Delaware? State Law and Shipping Guide

What current Delaware law says about kratom

Delaware's current legal position must be separated from the text lawmakers approved in HS 1 for HB 332. The operative Delaware Code does not contain the proposed Chapter 30S, and the state's Uniform Controlled Substances Act does not presently identify kratom, mitragynine, or 7-hydroxymitragynine as scheduled substances. At the statewide level, botanical kratom is therefore not prohibited simply because it is kratom.

Delaware's general age of majority is 18 under 1 Del. C. section 701, but that provision is not a kratom sales statute. It does not establish a special 18-and-older purchasing rule, and it should not be used to describe Delaware as an age-regulated kratom state. The more precise statement is that no kratom-specific statewide minimum purchase age is currently enacted. Kratom Paradise nevertheless treats kratom as an adult-oriented product and applies its own eligibility controls.

General food and labeling law still matters. Under 16 Del. C. section 3301, food includes articles used for human food or drink. Section 3302 prohibits manufacturing, selling, or trading food or drugs that are adulterated, misbranded, poisonous, or deleterious within the meaning of Chapter 33. Section 3304 addresses adulterated food, including substitution, concealed inferiority, contamination, and added ingredients that may make a food injurious. Section 3309 addresses misbranding, including false or misleading package statements and failures to state package quantity properly. Section 3312 supplies penalties for violations of sections 3302 through 3311.

Those provisions are general safeguards. They do not create Delaware-specific kratom alkaloid limits, mandatory certificates of analysis, batch registration, or a special kratom label template. A product may still violate state law if its contents or representations are false, misleading, adulterated, or otherwise noncompliant.

Delaware's 2026 kratom legislative timeline

• March 18, 2026Senate Bill 262 was introduced with a controlled-substance approach that would have prohibited commercial manufacture, sale, delivery, and distribution of kratom products.
• April 15, 2026Senate Substitute No. 1 for SB 262 was introduced. It revised the proposed criminal framework but remained a broad restriction on commercial kratom activity.
• March 26, 2026House Bill 332 was introduced with consumer-protection, disclosure, age, and marketing provisions.
• June 11, 2026House Substitute No. 1 replaced the original HB 332 proposal with a narrower 21-plus sales and marketing measure and an agency-report requirement.
• July 1, 2026HS 1 for HB 332 passed the Delaware General Assembly and was sent forward for governor action.
• July 21, 2026The official tracker still identified HS 1 for HB 332 as ready for governor action, while SS 1 for SB 262 remained in committee.

What the pending HS 1 for HB 332 would change

The pending measure would create Chapter 30S of Title 16. Proposed section 3001S defines kratom broadly to include parts of Mitragyna speciosa, extracts, resins, compounds, derivatives, mixtures, preparations, synthetic equivalents, and certain isomers and salts. It defines a kratom product as a product intended or marketed for human consumption that contains plant material, a derived alkaloid, a substance manufactured to mimic a naturally occurring alkaloid, or a combination of those substances.

Proposed section 3002S would prohibit selling, otherwise furnishing, or marketing kratom or a kratom product to a person under 21. The marketing definition includes specified cartoons, superheroes, video-game references, youth-associated symbols, copied trademarks, images of individuals appearing younger than 27, claims attractive to children, and products stored or displayed where nonemployees under 21 can access them. The proposal includes an affirmative defense based on photographic identification that would lead a reasonable person to believe the purchaser was at least 21. A violation would be a class B misdemeanor.

The bill would also require a report by January 1, 2027, on natural kratom, synthetic kratom, concentrated 7-hydroxymitragynine products, testing methods, possible retailer licensing, enforcement, penalties, staffing, and funding. That study language would not itself create immediate testing or licensing standards. Any future operating rules would need a valid legal basis and an effective date.

Powder, capsules, extracts, and other formats in Delaware

Current Delaware law does not divide kratom into separate legal categories based on format. Eligible botanical leaf powder, capsules, bulk products, and clearly identified mitragynine formats may be available, provided the product and its representations comply with applicable law. Package form does not excuse adulteration or a false ingredient, quantity, origin, or strength statement.

• Leaf powder: no Delaware kratom-specific statute currently prohibits ordinary Mitragyna speciosa leaf powder.
• Capsules: encapsulation does not create a different statewide legal category, but package count and contents should be accurately stated.
• Extracts and tablets: Delaware has not enacted a kratom-specific numerical alkaloid ceiling, though general food and labeling laws still apply.
• Bulk products: larger package quantity does not remove ordinary food, labeling, and consumer-protection obligations.
• Synthetic 7-OH products: Kratom Paradise does not sell synthetic 7-OH products. The pending bill expressly directs state agencies to examine synthetic and concentrated products, but that study provision is not a present product ban.

If HS 1 for HB 332 becomes law in its current form, its broad definition would reach liquid, pill, capsule, tablet, powder, gummy, shot, beverage, and other products intended or marketed for human consumption. The proposed age and marketing restrictions would not be confined to traditional leaf.

Current law should not be replaced with a bill summary

A passed bill can be highly relevant to fulfillment planning without being current law. Retailers may prepare for a possible 21-plus rule, update internal monitoring, and review marketing assets while still describing the legal status accurately. The controlling milestones are governor action, enactment, and the applicable effective date, not merely passage by the General Assembly.

Kratom shipping to Delaware

Kratom Paradise currently accepts eligible orders for Delaware delivery. The displayed estimate is 1–2 business days after carrier acceptance. This is an estimate rather than a guarantee; weekends, holidays, address corrections, weather, and carrier conditions can affect arrival.

Delaware currently has no kratom-specific statute requiring a particular online verification vendor, package warning, or adult-signature service. Delaware's separate delivery-sale rules for tobacco products and tobacco substitutes should not automatically be applied to kratom, which is not included in those categories merely because a retailer treats it as adult-oriented.

Carrier acceptance does not determine product legality. Before fulfillment, a seller should maintain accurate product identity, package quantity, supplier and lot information, and a current destination-law review. Because HS 1 for HB 332 is awaiting governor action, Delaware should be rechecked before a later shipment rather than relying indefinitely on this July 21 snapshot.

Official Delaware sources reviewed

• Delaware Code, Title 1, section 701
  General age-of-majority statute; it is not a kratom-specific sales rule.
• Delaware Code, Title 16, Chapter 33
  General food adulteration, misbranding, labeling, and penalty provisions.
• Delaware Code, Title 16, Chapter 47
  Current Uniform Controlled Substances Act.
• Delaware General Assembly: HS 1 for HB 332 status
  Official record showing passage and readiness for governor action.
• Delaware General Assembly: HS 1 for HB 332 text
  Proposed Chapter 30S definitions, age rule, marketing provisions, and report requirement.
• Delaware General Assembly: SS 1 for SB 262
  Official status of the separate controlled-substance proposal that remains in committee.

Last reviewed: July 21, 2026. Statewide information only; not legal advice.